Pharmaceutical Industry Reports
Phenylketonuria Treatment

Publié sur 16 July 2018 dans “Santé & Fitness”, langue – English. 8 pages.

Description de la publication:

KUVAN (sapropterin dihydrochloride) is a U.S. Food and Drug Administration approved drug which is majorly used in the treatment of Phenylketonuria. Plus

Afficher les étiquettes

Étiquettes: phenylketonuria treatment market growth

Lire

Autres publications de “Pharmaceutical Industry Reports”

Voir toutes les publications

Pharmaceutical Industry Reports Phenylketonuria Treatment

Autres publications de “Pharmaceutical Industry Reports”

Magazines connexes

Pharmaceutical Industry Reports
Phenylketonuria Treatment